Deborah C. Mash - Publications

University of Miami, Coral Gables, FL 
Neuroscience Biology, Pharmacology, Rehabilitation and Therapy

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Davis DA, Mondo K, Stern E, Annor AK, Murch SJ, Coyne TM, Brand LE, Niemeyer ME, Sharp S, Bradley WG, Cox PA, Mash DC. Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins. Plos One. 14: e0213346. PMID 30893348 DOI: 10.1371/Journal.Pone.0213346  0.317
2018 Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, ... ... Mash DC, et al. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer's disease target. Brain : a Journal of Neurology. PMID 30137212 DOI: 10.1093/Brain/Awy215  0.309
2018 Mash DC, Duque L, Page B, Allen-Ferdinand K. Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes. Frontiers in Pharmacology. 9: 529. PMID 29922156 DOI: 10.3389/Fphar.2018.00529  0.329
2018 McAninch EA, Rajan KB, Evans DA, Jo S, Chaker L, Peeters RP, Bennett DA, Mash DC, Bianco AC. A Common DIO2 Polymorphism And Alzheimer's Disease Dementia in African And European Americans. The Journal of Clinical Endocrinology and Metabolism. PMID 29481662 DOI: 10.1210/Jc.2017-01196  0.302
2017 Zhao Y, Perera G, Takahashi-Fujigasaki J, Mash DC, Paul J, Vonsattel G, Uchino A, Hasegawa K, Jeremy Nichols R, Holton JL, Murayama S, Dzamko N, Halliday GM. Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers. Brain : a Journal of Neurology. PMID 29253086 DOI: 10.1093/Brain/Awx344  0.315
2017 Wu C, Garamszegi SP, Xie X, Mash DC. Altered Dopamine Synaptic Markers in Postmortem Brain of Obese Subjects. Frontiers in Human Neuroscience. 11: 386. PMID 28824395 DOI: 10.3389/Fnhum.2017.00386  0.302
2017 Ribeiro EA, Scarpa JR, Garamszegi SP, Kasarskis A, Mash DC, Nestler EJ. Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder. Scientific Reports. 7: 5412. PMID 28710498 DOI: 10.1038/S41598-017-05720-3  0.347
2017 Doyle GA, Doucet-O'Hare TT, Hammond MJ, Crist RC, Ewing AD, Ferraro TN, Mash DC, Kazazian HH, Berrettini WH. Reading LINEs within the cocaine addicted brain. Brain and Behavior. 7: e00678. PMID 28523221 DOI: 10.1002/Brb3.678  0.339
2017 Vaillancourt K, Ernst C, Mash D, Turecki G. DNA Methylation Dynamics and Cocaine in the Brain: Progress and Prospects. Genes. 8. PMID 28498318 DOI: 10.3390/Genes8050138  0.34
2017 Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y. Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91]. Parkinsonism & Related Disorders. PMID 28392299 DOI: 10.1016/J.Parkreldis.2017.03.018  0.319
2016 Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y. Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy. Parkinsonism & Related Disorders. PMID 28034624 DOI: 10.1016/J.Parkreldis.2016.12.011  0.326
2016 Lee CT, Boeshore KL, Wu C, Becker KG, Errico SL, Mash DC, Freed WJ. Cocaine promotes primary human astrocyte proliferation via JNK-dependent up-regulation of cyclin A2. Restorative Neurology and Neuroscience. PMID 27834787 DOI: 10.3233/Rnn-160676  0.316
2016 Mash DC. Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum. Frontiers in Physiology. 7: 435. PMID 27790150 DOI: 10.3389/Fphys.2016.00435  0.338
2016 Lee CT, Chen J, Kindberg AA, Bendriem RM, Spivak CE, Williams MP, Richie CT, Handreck A, Mallon BS, Lupica CR, Lin DT, Harvey BK, Mash DC, Freed WJ. CYP3A5 Mediates Effects of Cocaine on Human Neocorticogenesis: Studies using an In Vitro 3D Self-Organized hPSC Model with a Single Cortex-Like Unit. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27534267 DOI: 10.1038/Npp.2016.156  0.368
2016 Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA. Do vervets and macaques respond differently to BMAA? Neurotoxicology. PMID 27133441 DOI: 10.1016/J.Neuro.2016.04.017  0.308
2016 Mash DC, Ameer B, Prou D, Howes JF, Maillet EL. Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents. Journal of Psychopharmacology (Oxford, England). PMID 27044509 DOI: 10.1177/0269881116641331  0.338
2015 Maillet EL, Milon N, Heghinian MD, Fishback J, Schürer SC, Garamszegi N, Mash DC. Noribogaine is a G-protein biased κ-opioid receptor agonist. Neuropharmacology. 99: 675-88. PMID 26302653 DOI: 10.1016/J.Neuropharm.2015.08.032  0.319
2015 Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y. Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & Related Disorders. 21: 1013-22. PMID 26255205 DOI: 10.1016/J.Parkreldis.2015.07.009  0.308
2015 Kelly JA, Boyle NT, Cole N, Slator GR, Colivicchi MA, Stefanini C, Gobbo OL, Scalabrino GA, Ryan SM, Elamin M, Walsh C, Vajda A, Goggin MM, Campbell M, Mash DC, et al. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology. 89: 193-203. PMID 25281210 DOI: 10.1016/J.Neuropharm.2014.09.024  0.342
2014 Enoch MA, Rosser AA, Zhou Z, Mash DC, Yuan Q, Goldman D. Expression of glutamatergic genes in healthy humans across 16 brain regions; altered expression in the hippocampus after chronic exposure to alcohol or cocaine. Genes, Brain, and Behavior. 13: 758-68. PMID 25262781 DOI: 10.1111/Gbb.12179  0.344
2013 Mash DC. Commentary on: Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ. Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium. J Forensic Sci 2012;57(6):1519-23. Journal of Forensic Sciences. 58: 559-61. PMID 24811527 DOI: 10.1111/1556-4029.12081  0.319
2013 Xie X, Basile M, Mash DC. Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-L-alanine. Neuroreport. 24: 779-84. PMID 23979257 DOI: 10.1097/Wnr.0B013E328363Fd89  0.302
2013 Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. Journal of Neurochemistry. 126: 591-603. PMID 23786406 DOI: 10.1111/Jnc.12345  0.309
2013 Sullivan D, Pinsonneault JK, Papp AC, Zhu H, Lemeshow S, Mash DC, Sadee W. Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Translational Psychiatry. 3: e222. PMID 23340505 DOI: 10.1038/Tp.2012.146  0.353
2012 Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine Drugs. 10: 509-20. PMID 22412816 DOI: 10.3390/Md10020509  0.682
2012 Enoch MA, Zhou Z, Kimura M, Mash DC, Yuan Q, Goldman D. GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. Plos One. 7: e29369. PMID 22253714 DOI: 10.1371/Journal.Pone.0029369  0.344
2012 Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33: 2160-71. PMID 21958961 DOI: 10.1016/J.Neurobiolaging.2011.08.014  0.304
2012 Luca C, Garamszegi S, Eldick D, Singer C, Mash D. Altered SIRT4 Expression Is Associated with Lewy Body Pathology (P01.209) Neurology. 78: P01.209-P01.209. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.209  0.333
2011 Zhou Z, Yuan Q, Mash DC, Goldman D. Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol. Proceedings of the National Academy of Sciences of the United States of America. 108: 6626-31. PMID 21464311 DOI: 10.1073/Pnas.1018514108  0.349
2011 Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, Sadee W. Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 753-62. PMID 21150907 DOI: 10.1038/Npp.2010.208  0.312
2011 Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Basile MJ, Mash DC. Catechols in post-mortem brain of patients with Parkinson disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 703-10. PMID 21073636 DOI: 10.1111/J.1468-1331.2010.03246.X  0.343
2010 Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 9: 620-635. PMID 21057660 DOI: 10.1016/J.Hal.2010.05.002  0.696
2009 Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 7-20. PMID 19929726 DOI: 10.3109/17482960903286009  0.302
2009 Mash DC, Duque L, Pablo J, Qin Y, Adi N, Hearn WL, Hyma BA, Karch SB, Druid H, Wetli CV. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Science International. 190: e13-9. PMID 19541436 DOI: 10.1016/J.Forsciint.2009.05.012  0.72
2009 Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurologica Scandinavica. 120: 216-25. PMID 19254284 DOI: 10.1111/J.1600-0404.2008.01150.X  0.706
2009 Jiang X, Zhou J, Mash DC, Marini AM, Lipsky RH. Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution. Neuromolecular Medicine. 11: 1-12. PMID 18946637 DOI: 10.1007/S12017-008-8051-0  0.322
2008 Lull ME, Freeman WM, Vrana KE, Mash DC. Correlating human and animal studies of cocaine abuse and gene expression. Annals of the New York Academy of Sciences. 1141: 58-75. PMID 18991951 DOI: 10.1196/Annals.1441.013  0.37
2008 Mann A, Miksys S, Lee A, Mash DC, Tyndale RF. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology. 55: 1147-55. PMID 18687346 DOI: 10.1016/J.Neuropharm.2008.07.017  0.327
2008 Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR. Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence. 94: 246-50. PMID 18055133 DOI: 10.1016/J.Drugalcdep.2007.09.020  0.723
2007 Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. The European Journal of Neuroscience. 26: 3229-36. PMID 18005064 DOI: 10.1111/J.1460-9568.2007.05932.X  0.323
2007 Mash DC, ffrench-Mullen J, Adi N, Qin Y, Buck A, Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. Plos One. 2: e1187. PMID 18000554 DOI: 10.1371/Journal.Pone.0001187  0.726
2007 Papapetropoulos S, Basel M, Mash DC. Dopaminergic innervation of the human striatum in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 286-8. PMID 17083095 DOI: 10.1002/Mds.21196  0.32
2007 Tannu N, Mash DC, Hemby SE. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Molecular Psychiatry. 12: 55-73. PMID 17075605 DOI: 10.1038/Sj.Mp.4001914  0.37
2006 Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expression. 13: 205-15. PMID 17193926 DOI: 10.3727/000000006783991827  0.698
2006 Drgon T, Lin Z, Wang GJ, Fowler J, Pablo J, Mash DC, Volkow N, Uhl GR. Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cellular and Molecular Neurobiology. 26: 875-89. PMID 16710758 DOI: 10.1007/S10571-006-9014-3  0.341
2005 Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC. Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. Journal of Neurochemistry. 95: 1785-93. PMID 16363995 DOI: 10.1111/J.1471-4159.2005.03517.X  0.377
2005 Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport. 16: 1489-93. PMID 16110277 DOI: 10.1097/01.Wnr.0000175617.39054.Ba  0.727
2005 Mash DC, Ouyang Q, Qin Y, Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. Journal of Neuroscience Methods. 143: 79-85. PMID 15763139 DOI: 10.1016/J.Jneumeth.2004.09.013  0.74
2004 Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC. National Association of Medical Examiners position paper on the certification of cocaine-related deaths. The American Journal of Forensic Medicine and Pathology. 25: 11-3. PMID 15075681 DOI: 10.1097/01.Paf.0000114041.70865.24  0.33
2004 Stephens BG, Jentzen JM, Karch S, Mash DC, Wetli CV. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. The American Journal of Forensic Medicine and Pathology. 25: 1-10. PMID 15075680 DOI: 10.1097/01.Paf.0000118960.58334.A9  0.32
2003 Hurley MJ, Mash DC, Jenner P. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain Journal of Neural Transmission. 110: 1279-1288. PMID 14628192 DOI: 10.1007/S00702-003-0033-7  0.345
2003 Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. The European Journal of Neuroscience. 18: 2668-72. PMID 14622169 DOI: 10.1046/J.1460-9568.2003.02963.X  0.37
2003 Tang WX, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. Journal of Neurochemistry. 85: 911-24. PMID 12716423 DOI: 10.1046/J.1471-4159.2003.01740.X  0.394
2003 Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2564-71. PMID 12684441  0.715
2003 Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons The Journal of Neuroscience. 23: 2564-2571. DOI: 10.1523/Jneurosci.23-07-02564.2003  0.731
2002 Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. Journal of Neurochemistry. 82: 1376-87. PMID 12354285 DOI: 10.1046/J.1471-4159.2002.01069.X  0.309
2002 Pérez S, Basile M, Mash DC, Mufson EJ. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. Journal of Chemical Neuroanatomy. 24: 109-16. PMID 12191727 DOI: 10.1016/S0891-0618(02)00034-0  0.317
2002 Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry. 81: 292-300. PMID 12064476 DOI: 10.1046/J.1471-4159.2002.00820.X  0.744
2002 Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proceedings of the National Academy of Sciences of the United States of America. 99: 6382-5. PMID 11959923 DOI: 10.1073/Pnas.092654299  0.372
2001 Baumann MH, Pablo J, Ali SF, Rothman RB, Mash DC. Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine Alkaloids: Chemistry and Biology. 56: 79-113. PMID 11705118 DOI: 10.1016/S0099-9598(01)56009-5  0.725
2001 Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, Kamlet JD, Hearn WL. Ibogaine in the treatment of heroin withdrawal. The Alkaloids. Chemistry and Biology. 56: 155-71. PMID 11705106 DOI: 10.1016/S0099-9598(01)56012-5  0.699
2001 Baumann MH, Rothman RB, Pablo JP, Mash DC. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 531-9. PMID 11303040  0.69
2001 Hurley MJ, Mash DC, Jenner P. Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease Molecular Brain Research. 87: 271-279. PMID 11245931 DOI: 10.1016/S0169-328X(01)00022-5  0.382
2000 Mash DC, Staley JK, Izenwasser S, Basile M, Ruttenber AJ. Serotonin transporters upregulate with chronic cocaine use. Journal of Chemical Neuroanatomy. 20: 271-80. PMID 11207425 DOI: 10.1016/S0891-0618(00)00102-2  0.366
2000 Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Annals of the New York Academy of Sciences. 914: 394-401. PMID 11085338 DOI: 10.1111/J.1749-6632.2000.Tb05213.X  0.705
2000 Baumann MH, Pablo JP, Ali SF, Rothman RB, Mash DC. Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine. Annals of the New York Academy of Sciences. 914: 354-68. PMID 11085335 DOI: 10.1111/J.1749-6632.2000.Tb05210.X  0.718
2000 Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB. Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Brain Research. Molecular Brain Research. 80: 123-31. PMID 11038245 DOI: 10.1016/S0169-328X(00)00111-X  0.309
2000 Hurley MJ, Mash DC, Jenner P. Adenosine A(2A) receptor mRNA expression in Parkinson's disease Neuroscience Letters. 291: 54-58. PMID 10962152 DOI: 10.1016/S0304-3940(00)01371-9  0.332
1999 Chen L, Segal DM, Moraes CT, Mash DC. Dopamine transporter mRNA in autopsy studies of chronic cocaine users Molecular Brain Research. 73: 181-185. PMID 10581411 DOI: 10.1016/S0169-328X(99)00233-8  0.365
1999 Izenwasser S, Staley JK, Cohn S, Mash DC. Characterization of kappa1-opioid receptor binding in human insular cortex. Life Sciences. 65: 857-62. PMID 10465345 DOI: 10.1016/S0024-3205(99)00315-X  0.347
1999 Mash DC, Staley JK. D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims Annals of the New York Academy of Sciences. 877: 507-522. PMID 10415668 DOI: 10.1111/J.1749-6632.1999.Tb09286.X  0.387
1999 Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC. Noribogaine generalization to the ibogaine Stimulus: Correlation with noribogaine concentration in rat brain Neuropsychopharmacology. 21: 119-126. PMID 10379526 DOI: 10.1016/S0893-133X(99)00003-2  0.705
1999 Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI. Immunocytochemical localization of the dopamine transporter in human brain. The Journal of Comparative Neurology. 409: 38-56. PMID 10363710 DOI: 10.1002/(Sici)1096-9861(19990621)409:1<38::Aid-Cne4>3.0.Co;2-1  0.334
1999 Miller GW, Erickson JD, Perez JT, Penland SN, Mash DC, Rye DB, Levey AI. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Experimental Neurology. 156: 138-48. PMID 10192785 DOI: 10.1006/Exnr.1998.7008  0.365
1999 Basile DV, Punch MS, Pablo J, Brenner B, Hearn WL, Mash DC. Indole alkaloids from tissue-cultured Tabernanthe iboga H. Bn Natural Product Letters. 13: 233-238. DOI: 10.1080/10575639908048791  0.686
1998 Mash DC, Kovera CA, Buck BE, Norenberg MD, Shapshak P, Hearn WL, Sanchez-Ramos J. Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence(a). Annals of the New York Academy of Sciences. 844: 274-292. PMID 29090804 DOI: 10.1111/J.1749-6632.1998.Tb08242.X  0.339
1998 Mufson EJ, Kahl U, Bowser R, Mash DC, Kordower JH, Deecher DC. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Annals of the New York Academy of Sciences. 863: 291-304. PMID 9928179 DOI: 10.1111/J.1749-6632.1998.Tb10703.X  0.351
1998 Efange SMN, Mash DC, Khare AB, Ouyang Q. Modified ibogaine fragments: Synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino[4,5- b]benzothiophenes Journal of Medicinal Chemistry. 41: 4486-4491. PMID 9804688 DOI: 10.1021/Jm980156Y  0.307
1998 Pablo JP, Mash DC. Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding. Neuroreport. 9: 109-14. PMID 9592058 DOI: 10.1097/00001756-199801050-00022  0.701
1998 Deecher DC, Mash DC, Staley JK, Mufson EJ. Characterization and localization of galanin receptors in human entorhinal cortex. Regulatory Peptides. 73: 149-59. PMID 9556077 DOI: 10.1016/S0167-0115(97)01067-7  0.331
1998 Mufson EJ, MA SY, Jaffar S, Ciliax BJ, Joyce J, Cochran E, Mash DC, Kordower JH, Levey AI. AGE RELATED CHANGES IN DOPAMINE TRANSPORTER IMMUNOREACTIVITY WITHIN THE HUMAN SUBSTANTIA NIGRA Journal of Neuropathology and Experimental Neurology. 57: 510. DOI: 10.1097/00005072-199805000-00184  0.302
1997 Staley JK, Mash DC, Parsons SM, Khare AB, Efange SMN. Pharmacological characterization of the vesamicol analogue (+)-[125I]MIBT in primate brain European Journal of Pharmacology. 338: 159-169. PMID 9455998 DOI: 10.1016/S0014-2999(97)81944-9  0.311
1997 Mash DC. Are neuroadaptations in D3 dopamine receptors linked to the development of cocaine dependence? Molecular Psychiatry. 2: 7-8. PMID 9154209 DOI: 10.1038/Sj.Mp.4000230  0.351
1997 Segal DM, Moraes CT, Mash DC. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities Molecular Brain Research. 45: 335-339. PMID 9149110 DOI: 10.1016/S0169-328X(97)00025-9  0.375
1997 Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Annals of Neurology. 41: 530-9. PMID 9124811 DOI: 10.1002/Ana.410410417  0.361
1997 Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Research. 747: 219-29. PMID 9045996 DOI: 10.1016/S0006-8993(96)01196-1  0.381
1997 Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: Epidemiologic findings provide new evidence for mechanisms of cocaine toxicity Journal of Forensic Sciences. 42: 25-31. PMID 8988571 DOI: 10.1520/Jfs14064J  0.339
1997 Staley JK, Rothman RB, Rice KC, Partilla J, Mash DC. κ2Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims The Journal of Neuroscience. 17: 8225-8233. DOI: 10.1523/Jneurosci.17-21-08225.1997  0.392
1996 Staley JK, Ouyang Q, Pablo J, Hearn WL, Flynn DD, Rothman RB, Rice KC, Mash DC. Pharmacological screen for activities of 12-hydroxyibogamine: A primary metabolite of the indole alkaloid ibogaine Psychopharmacology. 127: 10-18. PMID 8880938 DOI: 10.1007/Bf02805969  0.723
1996 Staley JK, Mash DC. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities Journal of Neuroscience. 16: 6100-6106. PMID 8815892 DOI: 10.1523/Jneurosci.16-19-06100.1996  0.405
1996 Wetli CV, Mash DC, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome American Journal of Emergency Medicine. 14: 425-428. PMID 8768172 DOI: 10.1016/S0735-6757(96)90066-2  0.302
1995 Flynn DD, Ferrari-DiLeo G, Levey AI, Mash DC. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. Life Sciences. 56: 869-76. PMID 10188787 DOI: 10.1016/0024-3205(95)00022-X  0.311
1995 Hearn WL, Pablo J, Hime GW, Mash DC. Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry. Journal of Analytical Toxicology. 19: 427-34. PMID 8926737 DOI: 10.1093/Jat/19.6.427  0.681
1995 Staley JK, Boja JW, Carroll FI, Seltzman HH, Wyrick CD, Lewin AH, Abraham P, Mash DC. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121 Synapse. 21: 364-372. PMID 8869167 DOI: 10.1002/Syn.890210412  0.377
1995 Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AI. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. Journal of Neurochemistry. 64: 1888-91. PMID 7891119 DOI: 10.1046/J.1471-4159.1995.64041888.X  0.305
1995 Ferrari-DiLeo G, Mash DC, Flynn DD. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease Molecular and Chemical Neuropathology. 24: 69-91. PMID 7755848 DOI: 10.1007/Bf03160113  0.324
1995 Mash DC, Staley JK, Pablo JP, Holohean AM, Hackman JC, Davidoff RA. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neuroscience Letters. 192: 53-6. PMID 7675310 DOI: 10.1016/0304-3940(95)11608-Y  0.696
1995 Mash DC, Staley JK, Baumann MH, Rothman RB, Lee Hearn W. Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin Life Sciences. 57. PMID 7596224 DOI: 10.1016/0024-3205(95)00273-9  0.312
1995 Staley J, Wetli C, Ruttenber A, Lee Hearn W, Kung H, Mash D. Dopamine transporter and receptor autoradiography in cocaine psychosis and sudden death Biological Psychiatry. 37: 656-657. DOI: 10.1016/0006-3223(95)94638-D  0.355
1994 Staley JK, Basile M, Flynn DD, Mash DC. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: In vitro binding and autoradiographic characterization Journal of Neurochemistry. 62: 549-556. PMID 8294917 DOI: 10.1046/J.1471-4159.1994.62020549.X  0.369
1994 Uhl GR, Walther D, Mash D, Faucheux B, Javoy-Agid F. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Annals of Neurology. 35: 494-8. PMID 8154880 DOI: 10.1002/Ana.410350421  0.325
1994 Chakko S, Sepulveda S, Kessler KM, Sotomayor MC, Mash DC, Prineas RJ, Myerburg RJ. Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse) The American Journal of Cardiology. 74: 710-713. PMID 7942531 DOI: 10.1016/0002-9149(94)90315-8  0.302
1992 Mash DC, Zabetian CP. Sigma receptors are associated with cortical limbic areas in the primate brain Synapse. 12: 195-205. PMID 1481139 DOI: 10.1002/Syn.890120304  0.35
1992 Wang SZ, Zhu SZ, Mash DC, El-Fakahany EE. Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains Molecular Brain Research. 16: 64-70. PMID 1334201 DOI: 10.1016/0169-328X(92)90194-G  0.303
1991 Flynn DD, Weinstein DA, Mash DC. Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies Annals of Neurology. 29: 256-262. PMID 2042942 DOI: 10.1002/Ana.410290305  0.312
1991 Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry. 56: 698-701. PMID 1988563 DOI: 10.1111/J.1471-4159.1991.Tb08205.X  0.371
1991 Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice Experimental Neurology. 114: 73-81. PMID 1915737 DOI: 10.1016/0014-4886(91)90086-R  0.718
1990 Mash DC, Pablo J, Flynn DD, Efange SMN, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain Journal of Neurochemistry. 55: 1972-1979. PMID 2230804 DOI: 10.1111/J.1471-4159.1990.Tb05784.X  0.711
1990 Efange SM, Kung HF, Mash DC, Jabir M, Billings J, Pablo J, Dutta A, Freshler A. Pargyline-sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia. Synapse (New York, N.Y.). 5: 207-12. PMID 2111588 DOI: 10.1002/Syn.890050306  0.712
1989 Efange SM, Mash D, Hefti F, Kung HF, Billings J. Selective visualization of rodent locus ceruleus by a radiolabeled N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analog. Journal of Neurochemistry. 53: 459-64. PMID 2787390 DOI: 10.1111/J.1471-4159.1989.Tb07356.X  0.309
1989 Hefti F, Mash DC. Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease. Neurobiology of Aging. 10: 75-87. PMID 2547172 DOI: 10.1016/S0197-4580(89)80014-4  0.309
1985 Mash DC, Flynn DD, Kalinoski L, Potter LT. Circadian variations in radioligand binding to muscarine receptors in rat brain dependent upon endogenous agonist occupation. Brain Research. 331: 35-8. PMID 2985199 DOI: 10.1016/0006-8993(85)90712-7  0.3
Show low-probability matches.